NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.52
Delayed Data
As of Feb 26
 -0.03 / -5.45%
Today’s Change
0.50
Today|||52-Week Range
1.38
-17.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$28.4M

Company Description

NovaBay Pharmaceuticals, Inc. is a clinical stage biotechnology company developing an anti-infective platform of compounds called the Aganocide compounds, for the treatment or prevention of infections in hospital and non-hospital environments. The company operates through four business units: Dermatology, Opthalmology, Urology and Wound Care. It was formerly known as NovaCal Pharmaceuticals, Inc. NovaBay Pharmaceuticals was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Contact Information

NovaBay Pharmaceuticals, Inc.
5980 Horton Street
Emeryville California 94608
P:(510) 899-8800
Investor Relations:

Employees

Shareholders

Other institutional3.23%
Individual stakeholders23.89%
Mutual fund holders2.50%

Top Executives

Ramin NajafiChairman, President & Chief Executive Officer
Thomas J. PaulsonCFO, CAO, Secretary & Treasurer
Ken KrantzVice President-Medical Affairs
Roy J. WuSenior VP-Business & Corporate Development
Russell A. HoonVice President-Advanced Wound Care Unit

To view my watchlist

Not a member yet?

Sign up now for a free account